Genetic Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GENE and buy or sell other stocks, ETFs, and their options commission-free!

About GENE

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. 

CEO
Simon Morriss
CEOSimon Morriss
Employees
Employees
Headquarters
Fitzroy, Victoria (VIC)
HeadquartersFitzroy, Victoria (VIC)
Founded
1987
Founded1987
Employees
Employees

GENE Key Statistics

Market cap
17.35M
Market cap17.35M
Price-Earnings ratio
-0.55
Price-Earnings ratio-0.55
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.79
52 Week high$0.79
52 Week low
$0.76
52 Week low$0.76

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.